Maternal intrahepatic cholestasis disrupts neonatal fatty acid β-oxidation in term neonates: metabolomic profiling from a retrospective cohort
Frontiers in Pediatrics · 16.11.2026 · 14
DOI: 10.3389/fped.2026.1917603 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pediatrics, online erschienen am 16.11.2026. Verfasst von Zhirong Deng und 7 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Intrahepatic cholestasis of pregnancy (ICP) impacts perinatal outcomes and is associated with long-term metabolic disorders in offspring, although the mechanisms are not fully understood. On the basis of the developmental origins of health and disease hypothesis, maternal metabolic disturbances may permanently modify the metabolic pathways of offspring through intrauterine alterations. Nevertheless, the specific role of ICP in this process remains unclear.
Methods
We analyzed a cohort of 30 neonates born to mothers with ICP and 73 controls from the Sixth Affiliated Hospital of Sun Yat-sen University (2017–2023). Blood amino acids and acylcarnitines were quantified via liquid chromatography‒tandem mass spectrometry. Orthogonal partial least squares-discriminant analysis identified differentially abundant metabolites. Metabolic pathway analysis was conducted via MetaboAnalyst 6.0. A binary logistic regression model was used to evaluate diagnostic performance via receiver operating characteristic (ROC) curves.
Results
Neonates exposed to ICP demonstrated significant metabolic alterations, involving 10 acylcarnitines and 6 amino acids. Pathway analysis revealed disruptions in the mitochondrial β -oxidation of fatty acids, the urea cycle, and aspartate metabolism. A diagnostic model combining six metabolites achieved high accuracy (AUC: 0.986, 95% CI: 0.941–1.000). The C18:1-OH/C10 ratio was correlated with maternal bile acid levels ( r = 0.47, P < 0.05) and showed diagnostic potential (AUC = 0.923, 95% CI: 0.854–0.966).
Conclusion
This study is the first to suggest that ICP disrupts neonatal metabolic programming through bile acid-mediated suppression of fatty acid β -oxidation. The C18:1-OH/C10 ratio serves as a biomarker for maternal–fetal metabolic crosstalk, offering a potential target for early interventions.
Zitieren
APA
Deng, Z., Liu, B., Gu, X., Lin, C., Li, S., Hao, H., Xiao, X., & Liu, M. (2026). Maternal intrahepatic cholestasis disrupts neonatal fatty acid β-oxidation in term neonates: metabolomic profiling from a retrospective cohort. Frontiers in Pediatrics, 14. https://doi.org/10.3389/fped.2026.1917603
Vancouver
Deng Z, Liu B, Gu X, Lin C, Li S, Hao H, et al. Maternal intrahepatic cholestasis disrupts neonatal fatty acid β-oxidation in term neonates: metabolomic profiling from a retrospective cohort. Frontiers in Pediatrics. 2026;14. doi:10.3389/fped.2026.1917603
BibTeX
@article{Deng2026,
author = {Deng, Zhirong and Liu, Bingqing and Gu, Xia and Lin, Chuqin and Li, Sitao and Hao, Hu and Xiao, Xin and Liu, Mengxian},
title = {Maternal intrahepatic cholestasis disrupts neonatal fatty acid β-oxidation in term neonates: metabolomic profiling from a retrospective cohort},
journal = {Frontiers in Pediatrics},
year = {2026},
volume = {14},
doi = {10.3389/fped.2026.1917603}
}
EUVIMED